Overview

  • Product nameAnti-LYNX1 antibody [EPR6829]
    See all LYNX1 primary antibodies
  • Description
    Rabbit monoclonal [EPR6829] to LYNX1
  • Tested applicationsSuitable for: WBmore details
    Unsuitable for: Flow Cyt,ICC,IHC-P or IP
  • Species reactivity
    Reacts with: Mouse, Rat, Human
  • Immunogen

    A synthetic peptide corresponding to residues in Human LYNX1.

  • Positive control
    • BxPC3 and fetal brain lysates
  • General notes

    This product is a recombinant rabbit monoclonal antibody.

    Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.

Properties

Applications

Our Abpromise guarantee covers the use of ab125035 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/1000 - 1/10000. Predicted molecular weight: 13 kDa.
  • Application notesIs unsuitable for Flow Cyt,ICC,IHC-P or IP.
  • Target

    Anti-LYNX1 antibody [EPR6829] images

    • All lanes : Anti-LYNX1 antibody [EPR6829] (ab125035) at 1/1000 dilution

      Lane 1 : BxPC3 lysate
      Lane 2 : fetal brain lysate

      Lysates/proteins at 10 µg per lane.

      Secondary
      HRP labelled goat anti rabbit at 1/2000 dilution

      Predicted band size : 13 kDa
    • Equilibrium disassociation constant (KD)
      Learn more about KD

      Click here to learn more about KD

    References for Anti-LYNX1 antibody [EPR6829] (ab125035)

    ab125035 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab125035.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"